The molecular basis of cardiolipin-protein interactions implicated in intrinsic apoptosis
心磷脂-蛋白质相互作用的分子基础涉及内在细胞凋亡
基本信息
- 批准号:9342976
- 负责人:
- 金额:$ 36.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal TestingAnimalsApoptosisApoptoticBindingBiologicalBiological AssayBiophysicsCardiolipinsCardiovascular DiseasesCessation of lifeChemicalsCollaborationsComplexCytochrome c GroupDataDiseaseDrug DesignDrug TargetingElectron MicroscopyEquus caballusEventFeedbackFluorescenceFutureGenerationsHeartHuntington DiseaseInner mitochondrial membraneInterdisciplinary StudyInterventionLabelLinkLipidsMagicMalignant NeoplasmsMeasurementMediatingMedicalMembraneMembrane FusionMitochondriaMitochondrial ProteinsModelingModificationMolecularMolecular StructureNMR SpectroscopyNerve DegenerationNeurodegenerative DisordersOpticsOutcome StudyOuter Mitochondrial MembraneOxidesParkinson DiseasePeroxidasesPeroxidesPlayProcessPropertyProtein ConformationProteinsPublicationsPublishingReactive Oxygen SpeciesRecruitment ActivityResearch PersonnelResolutionRoleSamplingSignal TransductionSiteSolventsSpecificitySpectrum AnalysisStimulusStructureSystemTechniquesTestingUrsidae FamilyVariantVesicleWorkcytochrome cdesignexperienceexperimental studyflexibilityfluidityinhibitor/antagonistinsightmitochondrial membranemolecular dynamicsmutantneuron lossoxidationoxidized lipidperoxidationpolyunsaturated fatprematureprotein structurepublic health relevanceresponsesolid state nuclear magnetic resonancestable isotopestemsynergismtooluncontrolled cell growth
项目摘要
PROJECT SUMMARY
Malfunctioning of mitochondrial apoptosis is implicated in a range of neurodegenerative diseases and cancers,
where it leads to premature neuronal death or uncontrolled cell growth. Animal studies of neurodegenerative
disorders have shown the benefits of drugs that target early apoptotic events in mitochondria, but many critical
aspects specifics of the underlying molecular processes remain enigmatic. It is clear that mitochondrial
membranes undergo extensive remodeling, that oxidation of lipids plays a critical role, that redistributed lipid
species act as critical pro-apoptotic signals, and that mitochondrial proteins attain new apoptosis-specific
functions. The latter notably includes mitochondrial cytochrome c (cyt-c), as it performs two essential functions:
it catalyzes the oxidation of the mitochondrial lipid cardiolipin by reactive oxygen species, and cyt-c release is a
final irrevocable “death signal”. Informed by extensive preliminary studies, we have defined a new, integrated
model that ties together these events, and identifies a potential critical positive feedback loop that underlies the
earliest stages of mitochondrial apoptosis. We propose experiments that will test this model, which features at
its core a synergy of protein-lipid interactions and membrane structural changes. We will leverage cutting-edge
solid-state NMR spectroscopy and complementary techniques to elucidate how cyt-c and cardiolipin combine
and interact to trigger the pro-apoptotic peroxidase activity of cyt-c, through the induction of structural changes
in the protein. A recent publication and a broad array of preliminary results show how we can use advanced
solid-state NMR to provide the residue- and site-specific resolution that will be necessary to truly understand
the molecular features of this cardiolipin/cyt-c complex. Additional structural and functional measurements will
involve peroxidase assays, fluorescence measurements, electron microscopy, and various optical
spectroscopies. We will also detail how polyunsaturated cardiolipin, lipid oxidation, cyt-c, and other apoptotic
players impact the structure, fluidity, and stability of mitochondrial membranes. Again solid-state NMR will be a
powerful tool that provides unique insights into the molecular structure and dynamics of complex biological
membranes. The proposed integrated experimental approach, specifically including the use of state-of-the-art
magic-angle-spinning solid-state NMR, will be both essential and also unprecedented for this system. An array
of structural, biophysical, and functional measurements will be enabled by the abovementioned complementary
experimental techniques and executed by an experienced interdisciplinary research team. Our team has a
published track record of collaborative work and brings to bear an in-depth expertise in the key experimental
techniques, membrane biophysics, as well as the study of the roles of cyt-c and cardiolipin in apoptosis. Thus,
this project is certain to provide much-needed and unprecedented molecular insight into the pivotal early
stages of intrinsic apoptosis, and help inform ongoing and future efforts to target these events for drug design,
spanning applications from neurodegenerative disease to cancer.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Valerian E Kagan其他文献
Role of coenzyme Q and superoxide in vitamin E cycling.
辅酶 Q 和超氧化物在维生素 E 循环中的作用。
- DOI:
10.1007/978-1-4899-1789-8_20 - 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Valerian E Kagan;Y. Tyurina;Y. Tyurina;Eric Witt - 通讯作者:
Eric Witt
Deciphering of mitochondrial cardiolipin oxidative signaling in cerebral ischemia-reperfusion.
- DOI:
10.1038/jcbfm.2014.204. - 发表时间:
2015 - 期刊:
- 影响因子:
- 作者:
Jing Ji;Sophie Baart;Anna S Vikulina;Robert SB Clark;Tamil S Anthonymuthu;Vladimir A Tyurin;Lina Du;Claudette M St Croix;Yulia Y Tyurina;Jesse Lewis;Erin M Skoda;Anthony E Kline;Patrick M Kochanek;Peter Wipf;Valerian E Kagan;Hülya Bayır - 通讯作者:
lya Bayır
Sensitive and specific fluorescent probing of oxidative stress in different classes of membrane phospholipids in live cells using metabolically integrated cis-parinaric acid.
使用代谢整合的顺式石蜡油酸对活细胞中不同类别的膜磷脂中的氧化应激进行灵敏和特异的荧光探测。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Valerian E Kagan;Vladimir B. Ritov;Y. Tyurina;V. Tyurin - 通讯作者:
V. Tyurin
Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells.
Bcl-2 在 PC12 大鼠嗜铬细胞瘤细胞中抗氧化作用的直接证据。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:3.9
- 作者:
Y. Tyurina;V. Tyurin;Gianfranca Carta;P. Quinn;N. F. Schor;Valerian E Kagan - 通讯作者:
Valerian E Kagan
beta-Carotene. An antioxidant or a target of oxidative stress in cells?
β-胡萝卜素。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Billy W. Day;Stefania Bergamini;Y. Tyurina;Gianfranca Carta;V. Tyurin;Valerian E Kagan - 通讯作者:
Valerian E Kagan
Valerian E Kagan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Valerian E Kagan', 18)}}的其他基金
Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
- 批准号:
10540357 - 财政年份:2021
- 资助金额:
$ 36.58万 - 项目类别:
Therapeutic targeting MDSC-mediated immune suppression in cancer
针对癌症中 MDSC 介导的免疫抑制的治疗
- 批准号:
10340589 - 财政年份:2021
- 资助金额:
$ 36.58万 - 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
- 批准号:
10593942 - 财政年份:2020
- 资助金额:
$ 36.58万 - 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
- 批准号:
10176413 - 财政年份:2020
- 资助金额:
$ 36.58万 - 项目类别:
Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators
促铁死亡脂氧合酶的选择性抑制剂 - 下一代放射减缓剂
- 批准号:
10408142 - 财政年份:2020
- 资助金额:
$ 36.58万 - 项目类别:
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control
蛋白氧化磷脂相互作用决定上皮细胞命运和哮喘控制
- 批准号:
10375454 - 财政年份:2020
- 资助金额:
$ 36.58万 - 项目类别:
Ferroptosis as a Death Mechanism in Lung Injury - Project 2
铁死亡作为肺损伤的死亡机制 - 项目 2
- 批准号:
10399560 - 财政年份:2014
- 资助金额:
$ 36.58万 - 项目类别:
NANOTOX 2014, 7th International Nanotoxicology Congress
NANOTOX 2014,第七届国际纳米毒理学大会
- 批准号:
8718354 - 财政年份:2014
- 资助金额:
$ 36.58万 - 项目类别:
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
肺损伤中心磷脂的细胞内和细胞外信号传导
- 批准号:
8643330 - 财政年份:2014
- 资助金额:
$ 36.58万 - 项目类别:
相似海外基金
Bioreactors to Replace Animal Testing in Bone Research
生物反应器取代骨骼研究中的动物测试
- 批准号:
NC/Y500562/1 - 财政年份:2024
- 资助金额:
$ 36.58万 - 项目类别:
Training Grant
Animal testing of RNA aptamers as ALS drug candidate
RNA适体作为ALS候选药物的动物试验
- 批准号:
10453877 - 财政年份:2022
- 资助金额:
$ 36.58万 - 项目类别:
Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity
用于伴侣动物测试的两种 SARS-CoV-2 检测的实施和评估,以扩大 Vet-LIRN COVID-19 能力
- 批准号:
10665685 - 财政年份:2022
- 资助金额:
$ 36.58万 - 项目类别:
Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity
用于伴侣动物测试的两种 SARS-CoV-2 检测的实施和评估,以扩大 Vet-LIRN COVID-19 能力
- 批准号:
10609646 - 财政年份:2022
- 资助金额:
$ 36.58万 - 项目类别:
Animal testing of RNA aptamers as ALS drug candidate
RNA适体作为ALS候选药物的动物试验
- 批准号:
10646463 - 财政年份:2022
- 资助金额:
$ 36.58万 - 项目类别:
Data mining tool to build database to reduce animal testing in drug development.
数据挖掘工具建立数据库以减少药物开发中的动物试验。
- 批准号:
10042916 - 财政年份:2022
- 资助金额:
$ 36.58万 - 项目类别:
Grant for R&D
AgroPathogenMeter- developing a handheld platform for on-farm, rapid and, inexpensive animal testing
AgroPathogenMeter - 开发用于农场快速且廉价的动物测试的手持平台
- 批准号:
506300-2017 - 财政年份:2019
- 资助金额:
$ 36.58万 - 项目类别:
Strategic Projects - Group
Development of a novel alternative to animal testing for the evaluation of respiratory allergic sensitizing potential of chemicals
开发一种新的动物试验替代方案,用于评估化学品的呼吸道过敏致敏潜力
- 批准号:
18K11658 - 财政年份:2018
- 资助金额:
$ 36.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the feasibility of adapting a direct PCR diagnostics approach to in-field animal testing
研究将直接 PCR 诊断方法应用于现场动物测试的可行性
- 批准号:
104623 - 财政年份:2018
- 资助金额:
$ 36.58万 - 项目类别:
Collaborative R&D














{{item.name}}会员




